<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
      <PMID Version="1">35317845</PMID>
      <DateRevised>
        <Year>2022</Year>
        <Month>03</Month>
        <Day>29</Day>
      </DateRevised>
      <Article PubModel="Electronic">
        <Journal>
          <ISSN IssnType="Print">1750-9378</ISSN>
          <JournalIssue CitedMedium="Print">
            <Volume>17</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Mar</Month>
              <Day>22</Day>
            </PubDate>
          </JournalIssue>
          <Title>Infectious agents and cancer</Title>
          <ISOAbbreviation>Infect Agent Cancer</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Chlamydia pneumoniae infections and development of lung cancer: systematic review.</ArticleTitle>
        <Pagination>
          <StartPage>11</StartPage>
          <MedlinePgn>11</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="pii" ValidYN="Y">11</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1186/s13027-022-00425-3</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Chlamydia pneumoniae is an obligate intracellular pathogen and is a common cause of human respiratory diseases, including pneumonia. It has been already known to have a causal relationship with some chronic diseases such as chronic obstructive pulmonary disease, asthma, and atherosclerotic cardiovascular diseases. In this review, we aim to find out the association between C. pneumoniae infection and lung cancer.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">This is a systematic review on C. pneumoniae infection and the development of lung cancer, based on published articles consolidated from PubMed and Google Scholar on the topic.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Out of 46 articles, 27 were selected and screened through the process. Twenty-four articles positively supported the hypothesis with one animal model, while 3 of them were negatively supportive. Several proposed mechanisms explain the pathogenesis with some knowledge gaps.</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Although some studies showed an association between C. pneumoniae infection and lung cancer, whether the C. pneumoniae infection is an individual risk factor for lung cancer is still debatable. And it needs further experimental studies on both humans and animals with large observational studies to better understand the association between C. pneumoniae infection and lung cancer.</AbstractText>
          <CopyrightInformation>© 2022. The Author(s).</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Premachandra</LastName>
            <ForeName>Nadeesha Madushani</ForeName>
            <Initials>NM</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Microbiology, Faculty of Medicine and Allied Sciences, Rajarata University of Sri Lanka, Saliyapura, Sri Lanka.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jayaweera</LastName>
            <ForeName>J A A Sampath</ForeName>
            <Initials>JAAS</Initials>
            <Identifier Source="ORCID">0000-0001-5051-530X</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Microbiology, Faculty of Medicine and Allied Sciences, Rajarata University of Sri Lanka, Saliyapura, Sri Lanka. jaas071@gmail.com.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>03</Month>
          <Day>22</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Infect Agent Cancer</MedlineTA>
        <NlmUniqueID>101276559</NlmUniqueID>
        <ISSNLinking>1750-9378</ISSNLinking>
      </MedlineJournalInfo>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Chlamydia pneumoniae</Keyword>
        <Keyword MajorTopicYN="N">Lung cancer</Keyword>
        <Keyword MajorTopicYN="N">Risk factor</Keyword>
        <Keyword MajorTopicYN="N">Serology</Keyword>
      </KeywordList>
      <CoiStatement>The authors declare that they have no competing interests.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>10</Month>
          <Day>29</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>15</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>23</Day>
          <Hour>5</Hour>
          <Minute>36</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>24</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>24</Day>
          <Hour>6</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35317845</ArticleId>
        <ArticleId IdType="pmc">PMC8941765</ArticleId>
        <ArticleId IdType="doi">10.1186/s13027-022-00425-3</ArticleId>
        <ArticleId IdType="pii">10.1186/s13027-022-00425-3</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Kuo CC, Jackson LA, Campbell LA, Grayston JT. Chlamydia pneumoniae (TWAR) Clinical Microbiology Reviews. American Society for Microbiology; 1995 [cited 2021 Jun 21]. p. 451–61. https://journals.asm.org/journal/cmr</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC172870</ArticleId>
            <ArticleId IdType="pubmed">8665464</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>E. P. Is Chlamydophila pneumoniae an etiological agent of non-infectious diseases? Vol. 44, Postepy Mikrobiologii. 2005.</Citation>
        </Reference>
        <Reference>
          <Citation>Chlamydia pneumoniae Infection and Inflammatory Diseases [Internet]. [cited 2021 Jun 21]. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6345537/</Citation>
        </Reference>
        <Reference>
          <Citation>Porritt RA, Crother TR. Chlamydia pneumoniae infection and inflammatory diseases [Internet]. Vol. 7, Forum on Immunopathological Diseases and Therapeutics. Begell House Inc.; 2016 [cited 2021 Jun 21]. p. 237–54.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6345537</ArticleId>
            <ArticleId IdType="pubmed">30687565</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shen M, Cai L, Jiang K, Xu W, Chen Y, Xu Z. The therapeutic role of inhibition of miR-328 on pulmonary carcinoma induced by chlamydia pneumoniae through targeting histone H2AX. Cancer Biomarkers. 2019;</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30614802</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bray F, Ferlay J, Soerjomataram I, et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424. doi: 10.3322/caac.21492.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3322/caac.21492</ArticleId>
            <ArticleId IdType="pubmed">30207593</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zheng M. Classification and pathology of lung cancer. Surg Oncol Clin N Am. 2016;25(3):447–468. doi: 10.1016/j.soc.2016.02.003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.soc.2016.02.003</ArticleId>
            <ArticleId IdType="pubmed">27261908</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rizzo A, Carratelli CR, De Filippis A, Nazario B, Tufano MA, Buommino E. Transforming Chlamydia pneumoniae in human mesothelial cells. Int Microbiol. 2015;17(4):2568.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26421735</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xu X, Liu Z, Xiong W, Qiu M, Kang S, Xu Q, Cai L, He F. Combined and interaction effect of chlamydia pneumoniae infection and smoking on lung cancer: a case-control study in Southeast China. BMC Cancer. 2020;20(1):903. doi: 10.1186/s12885-020-07418-8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s12885-020-07418-8</ArticleId>
            <ArticleId IdType="pmc">PMC7510273</ArticleId>
            <ArticleId IdType="pubmed">32962687</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chaturvedi AK, Gaydos CA, Agreda P, Holden JP, Chatterjee N, Goedert JJ, et al.  Chlamydia pneumoniae infection and risk for lung cancer. Cancer Epidemiol Biomark Prev. 2010;19(6):879. doi: 10.1158/1055-9965.EPI-09-1261.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1158/1055-9965.EPI-09-1261</ArticleId>
            <ArticleId IdType="pubmed">20501758</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Littman AJ, White E, Jackson LA, Thornquist MD, Gaydos CA, Goodman GE, Vaughan TL. Chlamydia pneumoniae infection and risk of lung cancer. Cancer Epidemiol Biomark Prev. 2004;13(10):1624–1630.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15466979</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xiong WM, Xu QP, Xiao RD, Hu ZJ, Cai L, He F. Genome-wide DNA methylation and RNA expression profiles identified RIPK3 as a differentially methylated gene in Chlamydia pneumoniae infection lung carcinoma patients in China. Cancer Manag Res. 2019;28(11):5785–5797. doi: 10.2147/CMAR.S186217.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2147/CMAR.S186217</ArticleId>
            <ArticleId IdType="pmc">PMC6607209</ArticleId>
            <ArticleId IdType="pubmed">31388311</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jackson LA, Wang SP, Nazar-Stewart V, Grayston JT, Vaughan TL. Association of Chlamydia pneumoniae immunoglobulin A seropositivity and risk of lung cancer. Cancer Epidemiol Biomark Prev. 2000;9(11):1263–1266.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11097237</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Laurila AL, Anttila T, Läärä E, Bloigu A, Virtamo J, Albanes D, Leinonen M, Saikku P. Serological evidence of an association between Chlamydia pneumoniae infection and lung cancer. Int J Cancer. 1997;74(1):31–34. doi: 10.1002/(sici)1097-0215(19970220)74:1&lt;31::aid-ijc6&gt;3.0.co;2-1.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/(sici)1097-0215(19970220)74:1&lt;31::aid-ijc6&gt;3.0.co;2-1</ArticleId>
            <ArticleId IdType="pubmed">9036866</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu Z, Su M, Yu SC, Yin ZH, Zhou BS. Association of Chlamydia pneumoniae immunoglobulin G antibodies with the risk of lung cancer among non-smoking women in Liaoning, China. Thorac Cancer. 2010;1(3):126–129. doi: 10.1111/j.1759-7714.2010.00021.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1759-7714.2010.00021.x</ArticleId>
            <ArticleId IdType="pubmed">27755800</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kocazeybek B. Chronic Chlamydophila pneumoniae infection in lung cancer, a risk factor: a case-control study. J Med Microbiol. 2003;52(Pt 8):721–726. doi: 10.1099/jmm.0.04845-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1099/jmm.0.04845-0</ArticleId>
            <ArticleId IdType="pubmed">12867569</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Koyi H, Brandén E, Gnarpe J, Gnarpe H, Steen B. An association between chronic infection with Chlamydia pneumoniae and lung cancer. A prospective 2-year study. APIS. 2001;109(9):572–580. doi: 10.1034/j.1600-0463.2001.d01-177.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1034/j.1600-0463.2001.d01-177.x</ArticleId>
            <ArticleId IdType="pubmed">11878709</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sessa R, Santino I, Di Pietro M, Schiavoni G, Ripa C, Galdiero M, Iannone M, Izzo L, Mingazzini PI, Bolognese A, Del Piano M. No evidence of involvement of Chlamydia pneumoniae in lung cancer by means of quantitative real-time polymerase chain reaction. Int J Immunopathol Pharmacol. 2008;21(2):415–420. doi: 10.1177/039463200802100221.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1177/039463200802100221</ArticleId>
            <ArticleId IdType="pubmed">18547487</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Smith JS, Kumlin U, Nyberg F, Fortes C, Zaridze D, Ahrens W, Bruske-Hohlfeld I, Constantinescu V, Ting J, Benhamou S, Simonato L, Boman J, Gaborieau V, Boffetta P. Lack of association between serum antibodies of Chlamydia pneumoniae infection and the risk of lung cancer. Int J Cancer. 2008;123(10):2469–2471. doi: 10.1002/ijc.23814.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/ijc.23814</ArticleId>
            <ArticleId IdType="pubmed">18720403</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Koh WP, Chow VT, Phoon MC, Ramachandran N, Seow A. Lack of association between chronic Chlamydophila pneumoniae infection and lung cancer among nonsmoking Chinese women in Singapore. Int J Cancer. 2005;114(3):502–504. doi: 10.1002/ijc.20745.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/ijc.20745</ArticleId>
            <ArticleId IdType="pubmed">15578725</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Laurila AL, Von Hertzen L, Saikku P. Chlamydia pneumoniae and chronic lung diseases. Scand J Infect Dis. Supplement. 1997.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9259079</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhan P, Suo LJ, Qian Q, Shen XK, Qiu LX, Yu LK, et al.  Chlamydia pneumoniae infection and lung cancer risk: a meta-analysis. Eur J Cancer. 2011;47(5):7854. doi: 10.1016/j.ejca.2010.11.003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ejca.2010.11.003</ArticleId>
            <ArticleId IdType="pubmed">21194924</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Littman AJ, Jackson LA, Vaughan TL. Chlamydia pneumoniae and lung cancer: epidemiologic evidence. Cancer Epidemiol Biomark Prev. 2005;14(4):773–778. doi: 10.1158/1055-9965.EPI-04-0599.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1158/1055-9965.EPI-04-0599</ArticleId>
            <ArticleId IdType="pubmed">15824142</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chu DJ, Guo SG, Pan CF, Wang J, Du Y, Lu XF, Yu ZY. An experimental model for induction of lung cancer in rats by Chlamydia pneumoniae. Asian Pac J Cancer Prev. 2012;13(6):2819–2822. doi: 10.7314/apjcp.2012.13.6.2819.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.7314/apjcp.2012.13.6.2819</ArticleId>
            <ArticleId IdType="pubmed">22938465</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang C, Zhang N, Gao L. Association between Chlamydia pneumoniae infection and lung cancer: a meta-analysis. Transl Cancer Res. 2019;8(8):5845.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8797589</ArticleId>
            <ArticleId IdType="pubmed">35117038</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rozenbaum MH, Pechlivanoglou P, van der Werf TS, Lo-Ten-Foe JR, Postma MJ, Hak E. The role of Streptococcus pneumoniae in community-acquired pneumonia among adults in Europe: a meta-analysis. Eur J Clin Microbiol Infect Dis. 2013;32:305–316. doi: 10.1007/s10096-012-1778-4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s10096-012-1778-4</ArticleId>
            <ArticleId IdType="pubmed">23242464</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ruuskanen O, Lahti E, Jennings LC, Murdoch DR. Viral pneumonia. Lancet. 2011;377:1264–1275. doi: 10.1016/S0140-6736(10)61459-6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0140-6736(10)61459-6</ArticleId>
            <ArticleId IdType="pmc">PMC7138033</ArticleId>
            <ArticleId IdType="pubmed">21435708</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dillon C, Torres A, Niederman M, van der EM, Chalmers J, Welte T, Blasi F. Community-acquired pneumonia related to intracellular pathogens. Intensive Care Med. 2016. 10.1007/s00134-016-4394-4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27276986</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–249. doi: 10.3322/caac.21660.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3322/caac.21660</ArticleId>
            <ArticleId IdType="pubmed">33538338</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hua-Feng X, Yue-Ming W, Hong L, Junyi D. A meta-analysis of the association between Chlamydia pneumoniae infection and lung cancer risk. Indian J Cancer. 2015;52(Suppl 2):e112–e115. doi: 10.4103/0019-509X.172506.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4103/0019-509X.172506</ArticleId>
            <ArticleId IdType="pubmed">26728667</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Anttila T, Koskela P, Leinonen M, Laukkanen P, Hakulinen T, Lehtinen M, Pukkala E, Paavonen J, Saikku P. Chlamydia pneumoniae infection and the risk of female early-onset lung cancer. Int J Cancer. 2003;107(4):681–682. doi: 10.1002/ijc.11353.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/ijc.11353</ArticleId>
            <ArticleId IdType="pubmed">14520711</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
